Table 2:
Trends (AAPC) from 2010–2019 in unadjusted KRT incidence (pmp) at day 1 by country stratified by sex and PRD.
| Sex | PRD | ||||||
|---|---|---|---|---|---|---|---|
| Country | Male | Female | GN | DM | HT | Unknown | Other |
| Albania | +7.6 (+3.6; +11.7) | +8.6 (+3.0; +14.5) | +3.4 (−7.3; +15.3) | +17.8 (+10.9; +25.2) | +27.0 (+18.2; +36.5) | +0.9 (−14.1; +18.6) | +6.7 (−1.5; +15.5) |
| Belarusa | +3.1 (−14.0; +23.6) | +2.0 (−14.1; +21.1) | −0.7 (−17.7; +19.9) | +1.5 (−15.2; +21.6) | +10.4 (−12.4; +39.0) | −13.9 (−72.4; +168.5) | +3.4 (−15.3; +26.2) |
| Bosnia and Herzegovina | −1.3 (−2.9; +0.3) | −2.7 (−4.7; −0.6) | −3.6 (−7.8; +0.9) | −0.1 (−2.1; +2.0) | +1.0 (−2.7; +4.8) | −0.2 (−8.8; +9.2) | −5.3 (−10.8; +0.6) |
| Bulgariab | +2.0 (−2.8;+ 7.0) | −3.6 (−6.7; −0.4) | |||||
| Croatia | |||||||
| Cyprus | +8.8 (+2.6; +15.4) | +5.9 (−0.2; +12.5) | +12.5 (+2.1; +23.8) | +11.8 (+2.8; +21.5) | +11.7 (+0.6; +24.0) | −4.3 (−16.4; +9.6) | +1.6 (−5.5; +9.3) |
| Czech Republic | |||||||
| Estoniac | +1.8 (−2.1; +5.8) | −2.0 (−7.6; +3.9) | +0.9 (−6.0;+8.3) | −0.1 (−3.5; +3.5) | +6.2 (−7.4; +21.9) | N/A | −3.2 (−8.7; +2.5) |
| Greece | +4.7 (+4.0; +5.4) | +2.7 (+1.8; +3.7) | +2.0 (−0.3; +4.2) | +2.7 (+0.4; +5.2) | +2.6 (0.0; +5.4) | +6.4 (+4.3; +8.5) | +3.5 (+0.8; +6.2) |
| Lithuaniab | +2.4 (−4.9; +10.2) | +0.1 (−7.8; +8.7) | +8.4 (+1.2; +16.2) | +5.4 (−3.5; +15.1) | +3.4 (−8.3; +16.5) | −21.4 (−49.0; +21.2) | +7.7 (−9.4; +28.0) |
| Latvia | +2.0 (−1.1; +5.3) | −2.0 (−6.3; +2.5) | +0.3 (−3.9; +4.7) | +5.0 (−1.1; +11.5) | −1.7 (−13.7; +11.9) | +3.6 (−4.2; +12.0) | −2.0 (−7.6; +3.9) |
| North Macedonia | +4.3 (+2.5; +6.2) | +4.7 (+1.9; +7.7) | +1.1 (−3.9; +6.5) | +7.8 (+4.3; +11.4) | +2.1 (+0.2; +4.0) | +4.5 (−1.1; +10.4) | +4.9 (+1.5; +8.4) |
| Poland | −5.9 (−7.9; −3.9) | −3.0 (−4.9; −0.9) | −3.7 (−5.0; −2.3) | +2.1 (−4.7; +9.2) | +4.0 (−0.1; +8.5) | ||
| Romaniad | +5.2 (+4.1; +6.4) | +4.8 (+3.6; +6.0) | −3.9 (−6.0; −0.9) | +2.8 (+0.2; +5.4) | +8.6 (+4.8; +12.6) | +10.0 (+7.1; +12.9) | +2.5 (+0.1; +4.9) |
| Russiab | +8.3 (+6.2; +10.5) | +9.6 (+7.5; +11.7) | +6.7 (+2.6; +10.9) | +12.5 (+7.6; +17.6) | +12.8 (+5.7; +20.3) | −15.1 (−29.1; +1.6) | +10.7 (+5.5; +16.1) |
| Serbia | |||||||
| Slovakiab | 0.0 (−3.1; +3.3) | −3.0 (−4.7; −1.4) | −1.5 (−3.8; +0.8) | −4.1 (−7.9; −0.1) | −4.8 (−12.2; +3.2) | +2.7 (−1.7; +7.2) | −0.3 (−2.6; +2.1) |
| Türkiye | |||||||
| Ukrainea,e | +5.7 (+1.9; +9.7) | +6.0 (+1.7; +10.4) | +3.9 (+0.4; +7.6) | +9.3 (+5.1; +13.7) | +11.2 (+5.8; +16.8) | −1.6 (−31.5; +41.5) | +6.1 (+2.3; +10.1) |
If cells are left empty, data are unavailable.
aPatients younger than 18 years of age are not reported (2019–2021 for Belarus; 2016–2019 for Ukraine).
bData include dialysis patients only (2013–2015 for Bulgaria, 2013 for Lithuania; 2015–2019 for Russia; 2010–2019 for Slovakia).
cFor 2012 renal vascular disease was not reported separately, but included into hypertension.
dThe incidence of pre-emptive kidney transplantation is underestimated by ∼30% for the entire period.
eData for 2010 do not include the regions Zakarpattya, Zaporizzha, and Kiev city, and data for 2011 do not include Kiev city.
Bold AAPC values depict the statistically significant trends.
Abbreviation: GN, glomerulonephritis.